People Briefs
This article was originally published in The Gray Sheet
Executive Summary
NuVasive appoints executive VP, general counsel; Danaher names senior VP and general counsel; and genomic informatics company Human Longevity acquires Cypher Genomics, and in the process names Cypher CEO Ashley Van Zeeland as head of the firm's pediatric business.
You may also be interested in...
Business Briefs
Hill-Rom's acquisition of Welch Allyn speeds ahead; Nuvasive builds its team; Philips divests pediatric respiratory products.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.